Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sulindac sulfone 是非甾体抗炎药舒林酸 (sulindac) 的代谢物。 它是醛糖还原酶的抑制剂 (IC50 =367 nM)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 287 | 现货 | ||
10 mg | ¥ 428 | 现货 | ||
25 mg | ¥ 735 | 现货 | ||
50 mg | ¥ 1,098 | 待询 | ||
100 mg | ¥ 1,653 | 待询 | ||
200 mg | ¥ 2,479 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 387 | 现货 |
产品描述 | Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac. Sulindac sulfone is an inhibitor of aldose reductase (IC50 =367 nM). |
靶点活性 | Aldose reductase:367 nM |
体外活性 | In vitro: Sulindac sulfone treatment also inhibited PGE2 production by HCA-7 cells with an IC50 of 360 mmol/L. Sulindac sulfone at 100 mmol/L reduced 6-ketoPGFα by 29.2%. Sulindac sulfone reduced the colony number of HCA-7 and HCT-116 with an EC50 of 50 mmol/l. Sulindac sulfone significantly decreased the expression of total cellular β-catenin (50% of control), pro-caspase 3 (49%), cyclin D1 (51%), and PPARδ (65%) in SW480 cells. No significant alteration in pro-caspase 3 or β-catenin expression was found in HCA7, LS174, or Caco-2 cells treated with sulindac sulfone. A dose-dependent reduction in TCF-mediated transcriptional activity was also observed in SW480 cells [1][2]. |
体内活性 | 体内研究:Sulindac sulfone 能够在大鼠的 azoxymethane (AOM) 结肠癌模型中降低发病率、多发性以及肿瘤负担。而对 HCA-7、HCT-116 异种移植瘤和癌细胞异种移植瘤的生长无影响[1]。 |
分子量 | 372.41 |
分子式 | C20H17FO4S |
CAS No. | 59864-04-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 2.54 mg/mL
DMSO: 50 mg/mL (134.26 mM), Sonication and heating are recommended.
Ethanol: > 3.83 mg/mL, Sonication and heating are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6852 mL | 13.4261 mL | 26.8521 mL | 67.1303 mL |
5 mM | 0.537 mL | 2.6852 mL | 5.3704 mL | 13.4261 mL | |
10 mM | 0.2685 mL | 1.3426 mL | 2.6852 mL | 6.713 mL | |
20 mM | 0.1343 mL | 0.6713 mL | 1.3426 mL | 3.3565 mL | |
50 mM | 0.0537 mL | 0.2685 mL | 0.537 mL | 1.3426 mL | |
100 mM | 0.0269 mL | 0.1343 mL | 0.2685 mL | 0.6713 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Sulindac sulfone 59864-04-9 Endocrinology/Hormones Immunology/Inflammation Metabolism Neuroscience Reductase COX Aldose Reductase inhibit Exisulind Inhibitor inhibitor